Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels

We examined anti-tumor effects of zoledronic acid (ZOL), one of the bisphosphonates agents clinically used for preventing loss of bone mass, on human mesothelioma cells bearing the wild-type p53 gene. ZOL-treated cells showed activation of caspase-3/7, -8 and -9, and increased sub-G1 phase fractions...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Okamoto, Shinya, Jiang, Yuanyuan, Kawamura, Kiyoko, Shingyoji, Masato, Fukamachi, Toshihiko, Tada, Yuji, Takiguchi, Yuichi, Tatsumi, Koichiro, Shimada, Hideaki, Hiroshima, Kenzo, Kobayashi, Hiroshi, Tagawa, Masatoshi
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3610651/
https://ncbi.nlm.nih.gov/pubmed/23555949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0060297
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados